Skip to content

Decoy Therapeutics Inc.: 10-K filed 2016-03-08

What Decoy Therapeutics Inc. reported in its annual report filed 2016-03-08 (fiscal FY 2015): 31 published measures, 104 facts as tagged in accession 0001615219-16-000118.

This filing

Form
10-K (annual report)
Filed
2016-03-08
Fiscal period
fiscal FY 2015
Accession
0001615219-16-000118 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Decoy Therapeutics Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-12-3195,069,838USD
At 2014-12-3135,611,398USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-12-312,877,430USD
At 2014-12-311,118,571USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-12-3192,192,408USD
At 2014-12-31-6,538,340USD
At 2014-02-260USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-7,892,807USD92
2015-01-01 to 2015-12-31-29,141,630USD365
2015-07-01 to 2015-09-30-8,152,844USD92
2015-04-01 to 2015-06-30-7,078,398USD91
2015-01-01 to 2015-03-31-6,017,581USD90
2014-10-01 to 2014-12-31-3,742,049USD92
2014-02-27 to 2014-12-31-8,010,860USD308
2014-02-26 to 2014-12-31-8,010,860USD309
2014-07-01 to 2014-09-30-1,986,437USD92
2014-04-01 to 2014-06-30-2,189,651USD91
2014-02-26 to 2014-03-31-92,723USD34

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-20,746,118USD365
2014-02-26 to 2014-12-31-6,480,866USD309

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-12-31265,617USD365
2014-02-26 to 2014-12-3176,141USD309

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-12-3180,843,751USD365
2014-02-26 to 2014-12-3140,411,160USD309

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-27,265,091USD365
2014-02-26 to 2014-12-31-76,141USD309

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-12-31-37,152,490USD
At 2014-12-31-8,010,860USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-12-31382,437USD
At 2014-12-3185,144USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-12-316,597,359USD365
2014-02-26 to 2014-12-311,462,061USD309

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-12-3192,247,617USD
At 2014-12-3134,224,549USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-12-312,847,401USD
At 2014-12-311,067,161USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-12-31875,646USD
At 2014-12-31578,653USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-10-01 to 2015-12-317,930,438USD92
2015-01-01 to 2015-12-3129,213,658USD365
2015-07-01 to 2015-09-308,167,481USD92
2015-04-01 to 2015-06-307,094,581USD91
2015-01-01 to 2015-03-316,021,158USD90
2014-10-01 to 2014-12-313,751,411USD92
2014-02-26 to 2014-12-318,029,806USD309
2014-07-01 to 2014-09-301,993,363USD92
2014-04-01 to 2014-06-302,192,309USD91
2014-02-26 to 2014-03-3192,723USD34

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-10-01 to 2015-12-313,309,055USD92
2015-01-01 to 2015-12-3112,749,379USD365
2015-07-01 to 2015-09-303,445,200USD92
2015-04-01 to 2015-06-303,190,178USD91
2015-01-01 to 2015-03-312,804,946USD90
2014-10-01 to 2014-12-311,965,121USD92
2014-02-26 to 2014-12-314,003,911USD309
2014-07-01 to 2014-09-30909,123USD92
2014-04-01 to 2014-06-301,099,644USD91
2014-02-26 to 2014-03-3130,023USD34

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-12-3115,741,618shares
At 2014-12-312,215,711shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-12-31129,367,978USD
At 2014-12-311,472,299USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2015-12-31-24,654USD
At 2014-12-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-12-31442,501USD
At 2014-12-3197,141USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-12-3160,064USD
At 2014-12-3111,997USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-12-310USD
At 2014-12-3150,000USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-12-3115,442USD
At 2014-12-3115,442USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-12-31908,574USD
At 2014-12-31370,396USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2015-12-31119,422USD
At 2014-12-31163,019USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-7,930,438USD92
2015-01-01 to 2015-12-31-29,213,658USD365
2015-07-01 to 2015-09-30-8,167,481USD92
2015-04-01 to 2015-06-30-7,094,581USD91
2015-01-01 to 2015-03-31-6,021,158USD90
2014-10-01 to 2014-12-31-3,751,411USD92
2014-02-26 to 2014-12-31-8,029,806USD309
2014-07-01 to 2014-09-30-1,993,363USD92
2014-04-01 to 2014-06-30-2,192,309USD91
2014-02-26 to 2014-03-31-92,723USD34

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-29,166,284USD365
2014-02-26 to 2014-12-31-8,010,860USD309

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-29,141,630USD365
2014-02-26 to 2014-12-31-8,010,860USD309

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-314,621,383USD92
2015-01-01 to 2015-12-3116,464,279USD365
2015-07-01 to 2015-09-304,722,281USD92
2015-04-01 to 2015-06-303,904,403USD91
2015-01-01 to 2015-03-313,216,212USD90
2014-10-01 to 2014-12-311,786,290USD92
2014-02-26 to 2014-12-314,025,895USD309
2014-07-01 to 2014-09-301,084,240USD92
2014-04-01 to 2014-06-301,092,665USD91
2014-02-26 to 2014-03-3162,700USD34

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-12-3149,881USD365
2014-02-26 to 2014-12-3111,997USD309

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-12-31621,393USD365
2014-02-26 to 2014-12-31254,253USD309

Inspect the source

Entity
Decoy Therapeutics Inc. / CIK 0001615219
Captured
2026-09-21T17:20:32.388Z
SEC response SHA-256
3dae29679ef228e32bff301a79640d7e283fcc5b87c08a4882faedfce1c66e98

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001615219.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))